drugset / Trial / NCT01378390

Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's Disease

NCT01378390 ↗

Phase 3 Terminated 56 enrolled Tigenix S.A.U.
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine safety and efficacy of eASCs (expanded adult stem cells) for treatment of complex perianal fistulas in patients with Crohn's disease.

Timeline

Start
2008-12
Primary completion
2010-02
Completion
2010-02

Outcome

Outcome not reported

Stopped: “After the investigators and experts in the field imput it became apparent that the protocol was not reflective of clinical reality. No safety issues reported.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Expanded autologous adipose-derived adult stem cells (eASCs) Cell therapy 2e+07 cells Other